107 related articles for article (PubMed ID: 16029043)
1. Synthesis and evaluation of insulin-human serum albumin conjugates.
Thibaudeau K; Léger R; Huang X; Robitaille M; Quraishi O; Soucy C; Bousquet-Gagnon N; van Wyk P; Paradis V; Castaigne JP; Bridon D
Bioconjug Chem; 2005; 16(4):1000-8. PubMed ID: 16029043
[TBL] [Abstract][Full Text] [Related]
2. Albumin-insulin conjugate releasing insulin slowly under physiological conditions: a new concept for long-acting insulin.
Shechter Y; Mironchik M; Rubinraut S; Saul A; Tsubery H; Fridkin M
Bioconjug Chem; 2005; 16(4):913-20. PubMed ID: 16029032
[TBL] [Abstract][Full Text] [Related]
3. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological properties of insulin-deoxycholic acid chemical conjugates.
Lee S; Kim K; Kumar TS; Lee J; Kim SK; Lee DY; Lee YK; Byun Y
Bioconjug Chem; 2005; 16(3):615-20. PubMed ID: 15898729
[TBL] [Abstract][Full Text] [Related]
5. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
6. Oral administration of a fusion protein containing eight GLP-1 analogues produced in Escherichia coli BL21(DE3) in streptozotocin-induced diabetic rats.
Hou J; Yan R; Ding D; Yang L; Wang C; Wu Z; Yu X; Li W; Li M
Biotechnol Lett; 2007 Oct; 29(10):1439-46. PubMed ID: 17581704
[TBL] [Abstract][Full Text] [Related]
7. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A
J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and structure-activity relationships of novel insulin receptor tyrosine kinase activators.
Lum RT; Cheng M; Cristobal CP; Goldfine ID; Evans JL; Keck JG; Macsata RW; Manchem VP; Matsumoto Y; Park SJ; Rao SS; Robinson L; Shi S; Spevak WR; Schow SR
J Med Chem; 2008 Oct; 51(19):6173-87. PubMed ID: 18788731
[TBL] [Abstract][Full Text] [Related]
9. Silk sericin-insulin bioconjugates: synthesis, characterization and biological activity.
Zhang YQ; Ma Y; Xia YY; Shen WD; Mao JP; Xue RY
J Control Release; 2006 Oct; 115(3):307-15. PubMed ID: 17034892
[TBL] [Abstract][Full Text] [Related]
10. Cross-linked human serum albumin dimer has the potential for use as a plasma-retaining agent for the fatty acid-conjugated antidiabetic drugs.
Taguchi K; Chuang VT; Yamasaki K; Urata Y; Tanaka R; Anraku M; Seo H; Kawai K; Maruyama T; Komatsu T; Otagiri M
J Pharm Pharmacol; 2015 Feb; 67(2):255-63. PubMed ID: 25556343
[TBL] [Abstract][Full Text] [Related]
11. Effect of fungal polysaccharides on the modulation of plasma proteins in streptozotocin-induced diabetic rats.
Kim SW; Hwang HJ; Kim HM; Lee MC; Shik Lee M; Choi JW; Yun JW
Proteomics; 2006 Oct; 6(19):5291-302. PubMed ID: 16947119
[TBL] [Abstract][Full Text] [Related]
12. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on non-diabetic and streptozotocin-diabetic rats.
Gao LH; Liu WP; Wang BL; Li L; Xie MJ; Li YR; Chen ZH; Chen XZ
Clin Chim Acta; 2006 Jun; 368(1-2):173-8. PubMed ID: 16487949
[TBL] [Abstract][Full Text] [Related]
13. Increased carnitine palmitoyl transferase 1 expression and decreased sterol regulatory element-binding protein 1c expression are associated with reduced intramuscular triglyceride accumulation after insulin therapy in high-fat-diet and streptozotocin-induced diabetic rats.
Bi Y; Cai M; Liang H; Sun W; Li X; Wang C; Zhu Y; Chen X; Li M; Weng J
Metabolism; 2009 Jun; 58(6):779-86. PubMed ID: 19375767
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of albumin conjugates of a truncated peptide YY analogue for half-life extension.
Ehrlich GK; Michel H; Truitt T; Riboulet W; Pop-Damkov P; Goelzer P; Hainzl D; Qureshi F; Lueckel B; Danho W; Conde-Knape K; Konkar A
Bioconjug Chem; 2013 Dec; 24(12):2015-24. PubMed ID: 24251972
[TBL] [Abstract][Full Text] [Related]
15. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats.
Niu Y; Liu W; Tian C; Xie M; Gao L; Chen Z; Chen X; Li L
Eur J Pharmacol; 2007 Oct; 572(2-3):213-9. PubMed ID: 17651728
[TBL] [Abstract][Full Text] [Related]
16. Insulin-induced immunohistochemical and morphological changes in pancreatic beta-cells of streptozotocin-treated diabetic rats.
Adewole SO; Ojewole JA
Methods Find Exp Clin Pharmacol; 2007 Sep; 29(7):447-55. PubMed ID: 17982509
[TBL] [Abstract][Full Text] [Related]
17. The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats.
Liu Z; Li J; Zeng Z; Liu M; Wang M
Chem Biol Interact; 2008 May; 173(1):68-75. PubMed ID: 18377884
[TBL] [Abstract][Full Text] [Related]
18. Kringle 5 peptide-albumin conjugates with anti-migratory activity.
Léger R; Benquet C; Huang X; Quraishi O; van Wyk P; Bridon D
Bioorg Med Chem Lett; 2004 Feb; 14(4):841-5. PubMed ID: 15012978
[TBL] [Abstract][Full Text] [Related]
19. Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery.
Kumar A; Lahiri SS; Singh H
Int J Pharm; 2006 Oct; 323(1-2):117-24. PubMed ID: 16828246
[TBL] [Abstract][Full Text] [Related]
20. pI-shifted insulin analogs with extended in vivo time action and favorable receptor selectivity.
Kohn WD; Micanovic R; Myers SL; Vick AM; Kahl SD; Zhang L; Strifler BA; Li S; Shang J; Beals JM; Mayer JP; DiMarchi RD
Peptides; 2007 Apr; 28(4):935-48. PubMed ID: 17328992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
